Elucidation of the TDP2-dependent repair pathway for DSBs induced by radiomimetic drugs revealed that the combination of radiomimetic drugs, TDP1 inhibitors, and TDP2 inhibitors can be used for cancer treatment. The gene discussed is TDP1; the disease is cancer.